{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:22:09Z","timestamp":1785147729686,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cellsig.2024.111107","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:28:15Z","timestamp":1708064895000},"page":"111107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker"],"prefix":"10.1016","volume":"117","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2024.111107_bb0005","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajhg.2009.10.001","article-title":"Identification of CANT1 mutations in Desbuquois dysplasia","volume":"85","author":"Huber","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cellsig.2024.111107_bb0010","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/ajmg.a.33404","article-title":"Mutation of CANT1 causes Desbuquois dysplasia","volume":"A 152A","author":"Faden","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.cellsig.2024.111107_bb0015","first-page":"240","article-title":"Cloning, expression and enzyme activity delineation of two novel CANT1 mutations:the disappearance of dimerization may indicate the change of protein conformation and even function","volume":"15","author":"Wang","year":"2020","journal-title":"J. Rare Diseas."},{"key":"10.1016\/j.cellsig.2024.111107_bb0020","first-page":"1","article-title":"Calcium-activated nucleotidase 1 silencing inhibits proliferation, migration, and invasion in human clear cell renal cell carcinoma","author":"Liu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.cellsig.2024.111107_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2010.12.046","article-title":"The androgen-regulated calcium-activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro","volume":"178","author":"Gerhardt","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.cellsig.2024.111107_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0000000000001045","article-title":"The effect and mechanism of miR-607\/CANT1 axis in lung squamous carcinoma","volume":"32","author":"Qiao","year":"2021","journal-title":"Anti-Cancer Drugs"},{"issue":"2","key":"10.1016\/j.cellsig.2024.111107_bb0035","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1080\/21655979.2021.2003131","article-title":"Calcium-activated nucleotides 1 (CANT1) -- driven nuclear factor-k-gene binding (NF-KB) signaling pathway facilitates the lung cancer progression","volume":"13","author":"Gao","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111107_bb0040","first-page":"1007","volume":"23","author":"Ting Liu","year":"2023","journal-title":"Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.BMC cancer"},{"key":"10.1016\/j.cellsig.2024.111107_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia."},{"key":"10.1016\/j.cellsig.2024.111107_bb0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111107_bb0055","first-page":"93","article-title":"Tumor neoantigens: from basic research to clinical applications [J]","volume":"12","author":"Jiang","year":"2019","journal-title":"J. Hematoloncol."},{"key":"10.1016\/j.cellsig.2024.111107_bb0060","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.cellsig.2024.111107_bb0065","first-page":"8","article-title":"Neoantigen targeting-dawn of a new era in cancer immunotherapy? [J]","volume":"2017","author":"Wirth","year":"1848","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111107_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2024.111107_bb0075","first-page":"3788","article-title":"Checkpoint markers and tumor microenvironment: what do we know?[J]","volume":"14","author":"Ephraim","year":"2022","journal-title":"Cancers(Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111107_bb0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0003-9861(02)00420-4","article-title":"Cloning,expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases","volume":"406","author":"Smith","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cellsig.2024.111107_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12885-022-09175-2","article-title":"CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro","volume":"22","author":"Yao","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2024.111107_bb0090","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.3389\/fimmu.2018.03154","article-title":"Overcoming resistance to combination radiation-immuntherapy:a focus on contributing pathways within the tumor microenvironment","volume":"9","author":"Darragh","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2024.111107_bb0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0092-8674(05)80059-5","article-title":"Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA4","volume":"71","author":"Chen","year":"1992","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111107_bb0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100000 human cancer genomes reveals the landscape of tumor mutational burden[J]","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"issue":"15","key":"10.1016\/j.cellsig.2024.111107_bb0105","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1158\/1078-0432.CCR-19-3529","volume":"26","author":"Ricciuti","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.cellsig.2024.111107_bb0110","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigentics in cancer[J]","volume":"358","author":"Esteller","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2024.111107_bb0115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11912-008-0067-y","article-title":"Melanoma and the tumor microenvironment","volume":"10","author":"Villanueva","year":"2008","journal-title":"Curr. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111107_bb0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12307-010-0040-9","article-title":"A digest on the role of the tumor microenvironment in gastrointestinal cancers","volume":"3","author":"Augsten","year":"2010","journal-title":"Cancer Microenviron."},{"issue":"2","key":"10.1016\/j.cellsig.2024.111107_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2003.09.001","article-title":"The possible role of matrix metalloproteinase (MMP) -2 and MMP-9 in cancer, e.g. acute leukemia","volume":"50","author":"Klein","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T20:33:53Z","timestamp":1776717233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656824000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":25,"alternative-id":["S0898656824000755"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111107","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111107"}}